Changes to Carelon’s (formerly AIM’s) provider portal for medical oncology program

On May 14, 2023, Carelon Medical Benefits Management (formerly known as AIM Specialty Health^®) will release enhancements to the provider portal for the medical oncology program. The goal of the enhancements is to make the process of submitting prior authorization requests easier.

Starting May 14, the look and functionality of the clinical intake screens will change. Among other changes, you’ll notice:

• An improved look and feel in the case entry screens
• That biomarker questions are no longer presented for clinical scenarios to which the questions don’t apply
• That changes to the drug dosing screens make it easier to enter cycle ranges and dates of administration

Register for a webinar to learn more

To learn more about the changes you’ll see when submitting prior authorization requests for medical oncology drugs, register for one of the following webinars, which will be hosted by Carelon. (All times are Eastern time.)

Additional information

If you have questions about Carelon’s provider portal or about submitting prior authorization requests for medical oncology drugs, email Carelon at MedicalOncologySolution@aimspecialtyhealth.com.

For more information about the medical oncology program, see the following pages of our ereferrals.bcbsm.com website:

• Blue Cross Medical Benefit Drugs
• BCN Medical Benefit Drugs

Carelon Medical Benefits Management is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to manage authorizations for select services.